TABLE 2.
Genetic interactions between fl(2)d and early acting general splicing regulators
| Maternal genotype | % female viability | N |
|---|---|---|
| fl(2)d1/+ | 65.3 | 329 |
| fl(2)d2/+ | 87.4 | 371 |
| snfJ210/+ | 83.6 | 465 |
| snfJ210/+; fl(2)d1/+ | 27.6**** | 680 |
| snfJ210/+; fl(2)d2/+ | 74.4*** | 863 |
| snf148/+ | 48.0 | 220 |
| snf148/+; fl(2)d1/+ | 11.1**** | 900 |
| snf148/+; fl(2)d2/+ | 45.6 | 1003 |
| snfJ210/+; +/+; P{w+, snf5mer/+} | 98.0 | 420 |
| snfJ210/+; fl(2)d1/+; P{w+, snf5mer/+} | 16.1**** | 419 |
| snfJ210/+; fl(2)d2/+; P{w+, snf5mer/+} | 79.3* | 945 |
| U2af38ΔE18/+ | 100 | 191 |
| fl(2)d1/U2af38ΔE18 | 25.8**** | 288 |
| fl(2)d2/U2af38ΔE18 | 90.1** | 346 |
Females of the genotype indicated were crossed to Sxl7BO males. Female progeny were scored relative to the number of male siblings. N, total progeny; two-tailed Fisher's exact test compared progeny from trans-heterozygous mothers to progeny from single-mutant heterozygous control mothers. ****P < 0.0001; ***P < 0.001; **P < 0.005; *P < 0.05.